Literature DB >> 28494446

Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.

Francesca Gualandi1, Fatima Zaraket, Michele Malagù, Giulia Parmeggiani, Cecilia Trabanelli, Sergio Fini, Xiao Dang, Xiaoming Wei, Mingyan Fang, Matteo Bertini, Roberto Ferrari, Alessandra Ferlini.   

Abstract

Brugada syndrome is a primary arrhythmic syndrome that accounts for 20% of all sudden cardiac death cases in individuals with a structurally normal heart. Pathogenic variants associated with Brugada syndrome have been identified in over 19 genes, with SCN5A as a pivotal gene accounting for nearly 30% of cases. In contrast to other arrhythmogenic channelopathies (such as long QT syndrome), digenic inheritance has never been reported in Brugada syndrome. Exploring 66 cardiac genes using a new custom next-generation sequencing panel, we identified a double heterozygosity for pathogenic mutations in SCN5A and TRPM4 in a Brugada syndrome patient. The parents were heterozygous for each variation. This novel finding highlights the role of mutation load in Brugada syndrome and strongly suggests the adoption of a gene panel to obtain an accurate genetic diagnosis, which is mandatory for risk stratification, prevention, and therapy.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Brugada syndrome; Digenic inheritance; Mutation load

Mesh:

Substances:

Year:  2017        PMID: 28494446     DOI: 10.1159/000471792

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

1.  Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.

Authors:  Zhong-He Zhang; Hector Barajas-Martínez; Hao Xia; Bian Li; John A Capra; Jerome Clatot; Gan-Xiao Chen; Xiu Chen; Bo Yang; Hong Jiang; Gary Tse; Yoshiyasu Aizawa; Michael H Gollob; Melvin Scheinman; Charles Antzelevitch; Dan Hu
Journal:  J Am Coll Cardiol       Date:  2021-10-19       Impact factor: 27.203

2.  Upregulation of transient receptor potential melastatin 4 (TRPM4) in ventricular fibroblasts from heart failure patients.

Authors:  Jianlin Feng; Pengyu Zong; Jiajie Yan; Zhichao Yue; Xin Li; Chevaughn Smith; Xun Ai; Lixia Yue
Journal:  Pflugers Arch       Date:  2021-02-16       Impact factor: 3.657

3.  Four TRPM4 Cation Channel Mutations Found in Cardiac Conduction Diseases Lead to Altered Protein Stability.

Authors:  Beatrice Bianchi; Lijo Cherian Ozhathil; Argelia Medeiros-Domingo; Michael H Gollob; Hugues Abriel
Journal:  Front Physiol       Date:  2018-03-08       Impact factor: 4.566

4.  Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification.

Authors:  Michelle M Monasky; Emanuele Micaglio; Emanuela T Locati; Carlo Pappone
Journal:  Front Cardiovasc Med       Date:  2021-04-21

5.  Hyperactivation of platelet-derived growth factor signalling contributes to arrhythmogenesis in Brugada syndrome.

Authors:  Hongkun Wang; Lizhen Xu; Shuai Han; Xiaochen Wang; Hao Wang; Jingjun Zhou; Jiaxi Shen; Zongkuai Yang; Luyang Yu; Zhouqing Huang; Tingyu Gong; Ming Qi; Fan Yang; Ping Liang
Journal:  Clin Transl Med       Date:  2022-02

Review 6.  Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.

Authors:  Csaba Dienes; Zsigmond Máté Kovács; Tamás Hézső; János Almássy; János Magyar; Tamás Bányász; Péter P Nánási; Balázs Horváth; Norbert Szentandrássy
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.